PMC:7335494 / 28793-28895 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7335494","sourcedb":"PMC","sourceid":"7335494","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7335494","text":"Patients received either 10 g/d of oligofructose-enriched inulin or maltodextrin (control) for 8 weeks","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T332","span":{"begin":58,"end":64},"obj":"Chemical"},{"id":"T333","span":{"begin":68,"end":80},"obj":"Chemical"}],"attributes":[{"id":"A332","pred":"chebi_id","subj":"T332","obj":"http://purl.obolibrary.org/obo/CHEBI_15443"},{"id":"A333","pred":"chebi_id","subj":"T333","obj":"http://purl.obolibrary.org/obo/CHEBI_25140"},{"subj":"T332","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T333","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#ec93e4","default":true}]}]}}